Efficacy of Edupression.Com® in Depressive Patients
Launched by MEDICAL UNIVERSITY OF VIENNA · Apr 8, 2021
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
The edupression.com® self-help app is an evidence-based low-level psychosocial intervention, which a can be used as as monotherapy as first-line treatment in mild to moderate depressive patients or as complimentary treatment independent of previous therapy response or depression severity. The two foundations of edupression.com® are evidence-based psychoeducation with CBT elements, as well as self-monitoring in the mood chart. Evidence for the efficacy of this approach stems from a large body of literature regarding eHealth (healthcare services provided electronically via the internet) appli...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male/female
- • Age 18-65 years
- • ICD-10 diagnosis F32.0 \& F32.1, depressive episode mild \& moderate \& F33.0 \& F33.1, Recurrent depressive disorder mild \& moderate (M.I.N.I.)
- • PHQ-9 (Patient Health Questionnaire-9) score ≥5
- • ability to be managed as outpatients
- • adherence to the study protocol incl. willingness and minimal experience to understand instructions for edupression.com®
- Exclusion Criteria:
- • previous or concurrent major medical or neurological illness
- • any history of non-response to either psychotherapy/eHealth interventions (min. 3 month) or medication (min. 6 weeks, adequate antidepressive drug dosing) or any kind of therapy resistance
- • participants in the active phase of other interventional studies
- • ICD-10 diagnosis of substance dependence within the past year, except for caffeine or nicotine or current substance abuse
- • ICD-10 diagnosis of schizophrenia, schizoaffective disorder, bipolar affective disorder, persistent mood disorders, or an anxiety disorder
- • being acutely suicidal either indicated by a score ≥3 on item 9 (suicidal thoughts) on the PHQ-9 or according to the investigator´s opinion
- • failures to comply with the study protocol or to follow the instructions of the investigating team
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Markus Dold, MD, Priv.Doz.
Study Chair
Medical University of Vienna
Lukas M Pezawas, MD, Prof.
Principal Investigator
Medical University of Vienna
Gabriele Fischer, MD, Prof.
Study Chair
Medical University of Vienna
Lucie Bartova, MD
Study Chair
Medical University of Vienna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials